Editorial
 REVISED NORMS FOR ISSUE OF PATENTS   
 Wednesday, August 27, 2014 
 The Section 3(d) of the amended Indian Patent Act of 2005 is a key safeguard against ever greening of a drug patent by the inventor companies by making some incremental changes to the original molecule. 
  Past Editorial...  
TODAY'S NEWS
12:00  [IST]Asterias Biotherapeutics gets US FDA nod to begin phase 1/2a trial of AST-OPC1 in patients with cervical complete spinal cord injury
11:00  [IST]EMD Millipore opens new Biomanufacturing Sciences Training Center facility in Tokyo
10:00  [IST]Pfizer, Merck ink pact to explore potential of combo of Xalkori and pembrolizumab in phase 1b clinical study
09:00  [IST]Boehringer Ingelheim, Eli Lilly launch type 2 diabetes drug Jardiance in US market
more news >>
TOP NEWS
08:00  [IST]MSF upset over inclusion of IP in ongoing negotiations of Regional Comprehensive Economic Partnership
08:00  [IST]MMC refers case of 'cut practice' followed by top Mumbai hospital to state govt
08:00  [IST]IPC to work with NACO to monitor safety of ARV drugs as part of PvPI programme
08:00  [IST]Separate counters for generics opened in medical stores in all districts of Haryana
08:00  [IST]Hyderabad to emerge as new biotechnology capital of India: Experts
08:00  [IST]Apex committee on clinical trials gives clearance to only 9 new trial proposals
more news >>
YESTERDAY'S NEWS
18:00  [IST]Novo Nordisk acquires manufacturing facility in New Hampshire from Olympus Biotech
17:00  [IST]US FDA approves GSK's sNDA for Promacta for use in SAA patients of insufficient response to IST
16:00  [IST]US FDA grants orphan drug status to Insys Therapeutics' pharmaceutical cannabidiol to treat brain cancer
15:00  [IST]Spring Bioscience introduces PD-L1 rabbit monoclonal IHC antibody for immunotherapy research
14:00  [IST]VIVUS buys topiramate-related patents from Janssen Pharma
13:00  [IST]US FDA approves Iroko Pharma's Zorvolex for management of osteoarthritis pain
more news >>
INTERVIEW  
KSPC works out strategies with Kerala govt to enforce Section 42 of Pharmacy Act in State
B Rajan, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |